Literature DB >> 9005872

Patients homozygous for the 17p11.2 duplication in Charcot-Marie-Tooth type 1A disease.

E LeGuern1, R Gouider, D Mabin, S Tardieu, N Birouk, P Parent, P Bouche, A Brice.   

Abstract

Charcot-Marie-Tooth type 1A disease is an inherited sensorimotor neuropathy that is most often associated with a duplication of chromosome 17p11.2. This region contains the gene of the peripheral myelin protein 22 (PMP22), which is responsible by a gene dosage effect for the Charcot-Marie-Tooth type 1A phenotype with 17p11.2 duplication. We performed a clinical, electrophysiological, and genetic study of a consanguinous Charcot-Marie-Tooth type 1A family with 4 affected siblings, 3 of whom were homozygous for the 17p11.2 duplication, the other a heterozygote. Comparison of phenotypes showed that the severity of the disease was variable among the homozygotes, one of whom was no more severely affected than the heterozygous sibling who was paucisymptomatic. These results suggest that the severity of the disease is not determined solely by the number of copies of the PMP22 gene.

Entities:  

Mesh:

Year:  1997        PMID: 9005872     DOI: 10.1002/ana.410410117

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  4 in total

Review 1.  Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.

Authors:  Henry Houlden; Mary M Reilly
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

2.  Variation in SIPA1L2 is correlated with phenotype modification in Charcot- Marie- Tooth disease type 1A.

Authors:  Feifei Tao; Gary W Beecham; Adriana P Rebelo; John Svaren; Susan H Blanton; John J Moran; Camila Lopez-Anido; Jasper M Morrow; Lisa Abreu; Devon Rizzo; Callyn A Kirk; Xingyao Wu; Shawna Feely; Camiel Verhamme; Mario A Saporta; David N Herrmann; John W Day; Charlotte J Sumner; Thomas E Lloyd; Jun Li; Sabrina W Yum; Franco Taroni; Frank Baas; Byung-Ok Choi; Davide Pareyson; Steven S Scherer; Mary M Reilly; Michael E Shy; Stephan Züchner
Journal:  Ann Neurol       Date:  2019-03       Impact factor: 10.422

Review 3.  Dejerine-Sottas syndrome grown to maturity: overview of genetic and morphological heterogeneity and follow-up of 25 patients.

Authors:  Anneke Gabreëls-Festen
Journal:  J Anat       Date:  2002-04       Impact factor: 2.610

Review 4.  Genetic modifiers and non-Mendelian aspects of CMT.

Authors:  Dana M Bis-Brewer; Sarah Fazal; Stephan Züchner
Journal:  Brain Res       Date:  2019-09-13       Impact factor: 3.252

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.